Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Jerzy Sitkowski

13PUBLICATIONS
34CO-AUTHORS
Main group metal chemistryCheminformatics and quantitative structure-activity relationshipsPowder and particle technologyRadiation and matterMetal organic frameworks
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

Sort by Publication Date:
|Jun 29, 2026
Physicochemical properties and biological activity of heteroleptic cyclometalated Rh(III) complexes. A comparative analysis with Ir(III) analogues based on 3,5-dimethyl-1-phenyl-1<i>H</i>-pyrazole and auxiliary ligands.

|Mar 27, 2026
Metabolomic Study of 7-Ethyl-9-(<i>N</i>-methyl)aminomethyl-10-hydroxycamptothecin Derivative (NMe)-The Chemotherapeutic Drug Candidate Versus Irinotecan (IR) on a Mouse Model.

Piotr Surynt, Beata Naumczuk, Magdalena Popławska

|Jul 12, 2025
Development of a Cyclodextrin-Based Drug Delivery System to Improve the Physicochemical Properties of Ceftobiprole as a Model Antibiotic.

Dariusz Boczar, Wojciech Bocian, Jerzy Sitkowski

|Dec 23, 2023
New 5-Substituted SN38 Derivatives: A Stability Study and Interaction with Model Nicked DNA by NMR and Molecular Modeling Methods.

Elżbieta Bednarek, Wojciech Bocian, Jerzy Sitkowski

|Oct 27, 2022
Insight on the Interaction between the Camptothecin Derivative and DNA Oligomer Mimicking the Target of Topo I Inhibitors.

Wojciech Bocian, Beata Naumczuk, Magdalena Urbanowicz

|May 26, 2022
Sawhorse-type ruthenium complexes with triazolopyrimidine ligands - what do they represent in terms of cytotoxic and CORM compounds?

Marzena Fandzloch, Tomasz Jędrzejewski, Joanna Wiśniewska

Pageof 3

Frequent Collaborators

6 joint publications

Wojciech Bocian

6 joint publications

Elżbieta Bednarek

5 joint publications

Beata Naumczuk

5 joint publications

Magdalena Urbanowicz

3 joint publications

Iwona Łakomska

2 joint publications

Lech Kozerski

2 joint publications

Joanna Masternak

2 joint publications

Katarzyna Kazimierczuk

2 joint publications

Katarzyna Wiktorska

2 joint publications

Andrzej Wojtczak

Frequent Collaborators

6 joint publications

Wojciech Bocian

6 joint publications

Elżbieta Bednarek

5 joint publications

Beata Naumczuk

5 joint publications

Magdalena Urbanowicz